SCHEMBL2324062

SCHEMBL2324062

CCOC(=O)c1cn[nH]c1CN

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
NPC1 O15118 4/20 0.46
RAB9A P51151 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 2/20 0.44
DPP4 P27487 3/20 0.44
MAPT P10636 2/20 0.43
HSD17B10 Q99714 1/20 0.42
MAPK1 P28482 1/20 0.41
HSP90AA1 P07900 1/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23301502 0.88 ALDH1A1 (0.63) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL7519074 0.85 KMT2A (0.64) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL10719430 0.85 KMT2A (0.64) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL16211814 0.84 KMT2A (0.63) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL20268155 0.84 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL21607839 0.84 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL21200577 0.84 KMT2A (0.62) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL3356506 0.84 KMT2A (0.62) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL11200214 0.84 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL23302081 0.81 KMT2A (0.59) ALDH1A1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021216661-A1 PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES, INC. (US) 2021-10-28 WO disclosed
EP-3157922-A1 PYRAZOLO-PYRIDINE DERIVATIVES AS KINASE INHIBITORS UCB Biopharma SPRL (BE) 2017-04-26 EP disclosed
WO-2015193167-A1 PYRAZOLO-PYRIDINE DERIVATIVES AS KINASE INHIBITORS UCB BIOPHARMA SPRL (BE) 2015-12-23 WO disclosed
EP-2663311-A2 PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS GlaxoSmithKline LLC (US) 2013-11-20 EP disclosed
WO-2012096928-A2 PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2012-07-19 WO disclosed
EP-2356117-A1 PYRAZOLOPYRIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2011-08-17 EP disclosed
WO-2010059788-A1 PYRAZOLOPYRIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2010-05-27 WO disclosed
EP-1781661-A2 VASOPRESSIN V1A ANTAGONISTS Ferring B.V. (NL) 2007-05-09 EP disclosed
WO-2006021213-A2 VASOPRESSIN V1A ANTAGONISTS FERRING B.V. (NL) 2006-03-02 WO disclosed
EP-1592693-A1 BENZAMIDE DERIVATIVES AS OXYTOCIN AGONISTS AND VASOPRESSIN ANTAGONISTS Ferring B.V. (NL) 2005-11-09 EP disclosed
WO-2004072083-A1 BENZAMIDE DERIVATIVES AS OXYTOCIN AGONISTS AND VASOPRESSIN ANTAGONISTS FERRING B.V. (NL) 2004-08-26 WO disclosed
EP-1157024-A1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS American Cyanamid Company (US) 2001-11-28 EP disclosed
WO-2000044749-A1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 WO disclosed
EP-0220695-A1 Herbicidal compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1987-05-06 EP disclosed